1. Survival benefit associated with human anti-mouse antibody (HAMA) in patients with B-cell malignancies

   • Ignacio Azinovic
   • Gerald L. DeNardo
   • Sally J. DeNardo

   Original Article 22 February 2006 Pages: 1451 - 1458

   

2. Increased liver temperature efficiently augments human cellular immune response: T-cell activation and possible monocyte translocation

   • Yohei Kida
   • Sachiyo Tsuji-Kawahara
   • Masaaki Miyazawa

   Original Article 21 February 2006 Pages: 1459 - 1469

   

3. Mechanism of action differences in the antitumor effects of transmembrane and secretory tumor necrosis factor-alpha in vitro and in vivo

   • Qingfen Li
   • Li Li
   • Zhuoya Li

   Original Article 23 March 2006 Pages: 1470 - 1479

   

4. In vitro priming of tumor-specific cytotoxic T lymphocytes using allogeneic dendritic cells derived from the human MUTZ-3 cell line

   • Saskia J. A. M. Santegoets
   • Marco W. J. Schreurs
   • Tanja D. de Gruijl

   Original Article 09 February 2006 Pages: 1480 - 1490

   

5. Antitumor effects of a xenogeneic survivin bone marrow derived dendritic cell vaccine against murine GL261 gliomas

   • Michael J. Ciesielski
   • Lisa Apfel
   • Robert A. Fenstermaker

   Original Article 17 February 2006 Pages: 1491 - 1503

   

6. A mechanistic study of immune system activation by fusion of antigens with the ligand-binding domain of CTLA4

   • Dhanalakshmi Chinnasamy
   • Matt Tector
   • Martin K. Oaks

   Original Article 13 April 2006 Pages: 1504 - 1514

   

7. STEAP, a prostate tumor antigen, is a target of human CD8⁺ T cells

   • Pedro M. S. Alves
   • Olivier Faure
   • Kostas Kosmatopoulos

   Original Article 19 April 2006 Pages: 1515 - 1523

   

8. Dendritic cell-based multi-epitope immunotherapy of hormone-refractory prostate carcinoma

   • Ying Waeckerle-Men
   • Edith Uetz-von Allmen
   • Silke Gillessen

   Original Article 13 April 2006 Pages: 1524 - 1533

   

9. Macrophage inflammatory protein (MIP)1α and MIP1β differentially regulate release of inflammatory cytokines and generation of tumoricidal monocytes in malignancy

   • Anamika Nath
   • Sreya Chattopadhya
   • Nawal K. Sharma

   Original Article 04 March 2006 Pages: 1534 - 1541

   

10. CD40 ligation restores cytolytic T lymphocyte response and eliminates fibrosarcoma in the peritoneum of mice lacking CD4⁺ T cells

    • Andrew Lodge
    • Ping Yu
    • Joel Shilyansky

    Original Article 21 February 2006 Pages: 1542 - 1552

    

11. Telomerase peptide vaccination: a phase I/II study in patients with non-small cell lung cancer

    • Paal F. Brunsvig
    • Steinar Aamdal
    • Gustav Gaudernack

    Original Article 21 February 2006 Pages: 1553 - 1564

    

12. Endoglin (CD105) is a target for an oral DNA vaccine against breast cancer

    • Sung-Hyung Lee
    • Noriko Mizutani
    • Ralph A. Reisfeld

    Original Article 25 March 2006 Pages: 1565 - 1574

    

13. Identification of a new HLA-A*0201-restricted cytotoxic T lymphocyte epitope from CML28

    • Jun-Feng Han
    • Ting-Ting Zhao
    • Yu-Zhang Wu

    Original Article 14 March 2006 Pages: 1575 - 1583

    

14. Soluble MICB in malignant diseases: analysis of diagnostic significance and correlation with soluble MICA

    • Stefan Holdenrieder
    • Petra Stieber
    • Helmut Rainer Salih

    Original Article 25 April 2006 Pages: 1584 - 1589

    

15. Target-selective activation of a TNF prodrug by urokinase-type plasminogen activator (uPA) mediated proteolytic processing at the cell surface

    • Jeannette Gerspach
    • Julia Németh
    • Klaus Pfizenmaier

    Original Article 25 April 2006 Pages: 1590 - 1600